• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ALINITY S ANTI-HCV REAGENT KIT; HEPATITIS C VIRUS ENCODED ANTIGENS (RECOMBINANT C100-3, HCR43)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ALINITY S ANTI-HCV REAGENT KIT; HEPATITIS C VIRUS ENCODED ANTIGENS (RECOMBINANT C100-3, HCR43) Back to Search Results
Catalog Number 06P04-60
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/08/2023
Event Type  malfunction  
Manufacturer Narrative
All available patient information was included.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer reported false reactive alinity s anti-hcv on (b)(6) 2023 and provided the following data: sample id (b)(6) was initial reactive and repeat reactive (no objective values provided.) confirmatory testing with nat was performed and the customer reported that the confirmatory results were negative.Customer stated that they have sent sample out to a reference lab.There was no reported impact to patient management.
 
Event Description
The customer reported false reactive alinity s anti-hcv on (b)(6) 2023 and provided the following data: sample id (b)(6) was initial reactive and repeat reactive (no objective values provided.) confirmatory testing with nat was performed and the customer reported that the confirmatory results were negative.Customer stated that they have sent sample out to a reference lab.There was no reported impact to patient management.Update: additional information received: the customer reported that sample 04816440665 was resulted as hcv pcr negative on (b)(6) 2023.The sample was sent out for additional testing, which generated positive hcv result (eia method) on (b)(6) 2023.
 
Manufacturer Narrative
The complaint investigation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, and device history record review, and field data review.Return testing was not completed as returns were not available.Data and information provided by the customer were reviewed and support the complaint issue without indication for any additional issue.Device history review did not identify any potential non-conformances, non-conformances, or deviations with the complaint lot.Ticket search by lot did not identify an increase in complaint activity for the complaint lot.The ticket trending review did not identify any trends.The overall performance of the alinity s anti-hcv reagent was reviewed using field data from customers.A review of field data for the overall performance of lot 54315be00 indicated the product was performing within product requirements.Labeling was reviewed and was found to address the customer reported issue.Based on the results of the investigation, alinity s anti-hcv reagent lot 54315be00 met performance specifications and no systemic issue or product deficiency was identified.
 
Event Description
The customer reported false reactive alinity s anti-hcv on(b)(6)2023 and provided the following data: sample id (b)(6)was initial reactive and repeat reactive (no objective values provided.) confirmatory testing with nat was performed and the customer reported that the confirmatory results were negative.Customer stated that they have sent sample out to a reference lab.There was no reported impact to patient management.Update: additional information received: the customer reported that sample (b)(6)was resulted as hcv pcr negative on (b)(6)2023.The sample was sent out for additional testing, which generated positive hcv result (eia method) on (b)(6)2023.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY S ANTI-HCV REAGENT KIT
Type of Device
HEPATITIS C VIRUS ENCODED ANTIGENS (RECOMBINANT C100-3, HCR43)
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key18422906
MDR Text Key331668318
Report Number3002809144-2023-00507
Device Sequence Number1
Product Code QHM
UDI-Device Identifier00380740117191
UDI-Public00380740117191
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BL 125677
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 02/08/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number06P04-60
Device Lot Number54315BE00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/30/2023
Supplement Dates Manufacturer Received01/02/2024
02/02/2024
Supplement Dates FDA Received01/11/2024
02/08/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/13/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY S SYSTEM, 06P16-01, (B)(6); ALNTY S SYSTEM, 06P16-01, (B)(6); ALNTY S SYSTEM, 06P16-01, (B)(6)
-
-